Charles E. Stacey
Chief Executive Officer at Cerecin, Inc.
Profile
Charles E.
Stacey is currently the President, Chief Executive Officer & Director at Cerecin, Inc. He has been in this position since 2015.
In terms of education, Dr. Stacey has a graduate degree from Imperial College London, an undergraduate degree from University College London, an MBA from London Business School, and a doctorate from King's College London.
Charles E. Stacey active positions
| Companies | Position | Start |
|---|---|---|
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Chief Executive Officer | 2015-06-01 |
Training of Charles E. Stacey
| London Business School | Masters Business Admin |
| Imperial College London | Graduate Degree |
| King's College London | Doctorate Degree |
| University College London | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Health Technology |
- Stock Market
- Insiders
- Charles E. Stacey
